Department of Cardiology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, PR China; Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, PR China; Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, PR China.
Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, PR China.
Biomaterials. 2025 Mar;314:122901. doi: 10.1016/j.biomaterials.2024.122901. Epub 2024 Oct 19.
Hypoxia and lactate-overexpressed tumor microenvironment always lead to poor therapeutic effect of radiotherapy. Here, platinum nanoparticles-embellished hafnium metal-organic framework (Hf-MOF-Pt NPs) were elaborately integrated with Shewanella oneidensis MR-1 (SO) to construct an engineered biohybrid platform (SO@Hf-MOF-Pt) for enhancing radiotherapy. Benefiting from the tumor-targeting and metabolic respiration characteristics of SO, SO@Hf-MOF-Pt could enrich in tumor sites and continuously metabolize the overexpressed lactate, which specifically downregulated the expression of hypoxia-inducible factor (HIF-1α), thereby relieving the radiosuppressive tumor microenvironment to some extent. Moreover, SO@Hf-MOF-Pt would react with tumor-overexpressed hydrogen peroxide (HO) to generate oxygen (O) and further inhibit the expression of HIF-1α, resulting in the downregulation of lactate dehydrogenase (LDHA) and subsequently reducing the lactate production. Under these multiple cascaded effects, the radiosuppressive tumor microenvironment was significantly reshaped, thus potentiating the radiosentization of SO@Hf-MOF-Pt and remarkably amplifying the therapeutic outcomes of radiotherapy. The designed biohybrid SO@Hf-MOF-Pt represented promising prospects in sensitizing radiotherapy via bacterium-based metabolic regulation.
缺氧和乳酸过度表达的肿瘤微环境总是导致放射治疗效果不佳。在这里,铂纳米粒子修饰的铪金属有机骨架(Hf-MOF-Pt NPs)与希瓦氏菌(Shewanella oneidensis MR-1,简称 SO)精心整合,构建了一个工程化的生物混合平台(SO@Hf-MOF-Pt),用于增强放射治疗。由于 SO 的肿瘤靶向和代谢呼吸特性,SO@Hf-MOF-Pt 可以在肿瘤部位富集,并不断代谢过度表达的乳酸,特异性地下调缺氧诱导因子(HIF-1α)的表达,从而在一定程度上缓解放射抑制性肿瘤微环境。此外,SO@Hf-MOF-Pt 会与肿瘤过度表达的过氧化氢(HO)反应生成氧气(O),并进一步抑制 HIF-1α 的表达,导致乳酸脱氢酶(LDHA)的下调,从而减少乳酸的产生。在这些多重级联效应下,放射抑制性肿瘤微环境得到了显著重塑,从而增强了 SO@Hf-MOF-Pt 的放射增敏作用,并显著放大了放射治疗的疗效。设计的生物混合 SO@Hf-MOF-Pt 通过基于细菌的代谢调节来增强放射治疗,具有广阔的应用前景。